Issue 26, 2024

A Fe(iii) intercalated clay nanoplatform for combined chemo/chemodynamic therapy

Abstract

A Fe(III) intercalated montmorillonite nanoplatform (Fe-MMT) was engineered for doxorubicin (DOX) loading. The constructed Fe-MMT/DOX nanoplatform could not only improve the production of H2O2 to enhance chemodynamic therapy but interfere with DNA damage repair to amplify the efficacy of DOX, proving an ideal combination of chemotherapy and chemodynamic therapy.

Graphical abstract: A Fe(iii) intercalated clay nanoplatform for combined chemo/chemodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
21 Dec 2023
Accepted
01 Mar 2024
First published
01 Mar 2024

Chem. Commun., 2024,60, 3535-3538

A Fe(III) intercalated clay nanoplatform for combined chemo/chemodynamic therapy

Y. Chen, J. Zhai, S. Wei, A. Tang and H. Yang, Chem. Commun., 2024, 60, 3535 DOI: 10.1039/D3CC06205H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements